Preclinical safety consulting is a crucial part of the development phase of new types of medication. The strict rules and regulations that pharmaceutical companies need to comply with, naturally, demand that a drug is safe to use. Safety in this context means that the benefits exceed possible negative side-effects. At Global Pathology Support we operate as an independent laboratory, providing pharmaceutical companies with proper preclinical safety consulting. How we do this? Read on or contact us today.
How preclinical safety consulting ensures the development of safe medications
Preclinical safety consulting consists of a toxicity study, during which a NOAEL is established. This stands for No-Observed Adverse Effect Level. In short, the NOAEL determines the highest tested dose of an experimental drug, without providing adverse effects in test subjects. When the NOAEL is determined, your company can initiate clinical testing.
Why choose Global Pathology Support?
Global Pathology Support plays a key role in delivering accurate and sound scientific pathology data in accordance with GLP (Good Laboratory Practice) regulations. Experience, drive, and profound knowledge of preclinical toxicity and carcinogenicity studies, ensure tangible results which your research and development team use to improve the safety of new medicine.
Take your research and development to the next level, contact us today
At Global Pathology Support we believe that proper scientific principles improve the wellbeing and health of people. If you need results before moving to the clinical testing phase, contact us and inquire about preclinical safety consulting and the availability by calling at +31 (0)70-314 24 04.